Key result
Stable Plaque-RADS phenotypes are strongly linked to <70% carotid stenosis.
Why the study?
To correlate quantitative carotid stenosis with qualitative Plaque-RADS categories using duplex ultrasonography in patients with CLTI, and evaluate associations with systemic markers of disease severity.
Does Plaque-RADS classification correlate with luminal stenosis, ABI, and TASC II classification in patients with CLTI?
Cross-Sectional (n=130)
No
Does Plaque-RADS classification correlate with luminal stenosis, ABI, and TASC II classification in patients with CLTI?
Answers are grounded in this paper and cite their sources.
Plaque-RADS identifies high-risk plaque phenotypes in patients with non-obstructive lesions, suggesting it should be used alongside luminal grading for risk stratification in systemic atherosclerosis.
Introduction. This cross-sectional study analyzed 260 carotid arteries in 130 consecutive patients with CLTI undergoing preoperative duplex ultrasonography at a tertiary vascular center between January 2021 and December 2023. To correlate quantitative carotid stenosis with qualitative Plaque-RADS categories using duplex ultrasonography in patients with chronic limb-threatening ischemia (CLTI), and to evaluate whether plaque phenotype is associated with systemic markers of disease severity, specifically the Ankle-Brachial Index (ABI) and TASC II classification. Methods. Stenosis was graded according to NASCET criteria. Plaque morphology was classified using the Plaque-RADS system (Types 1–4c). The Ankle-Brachial Index (ABI) and anatomical complexity of lower-extremity disease (TASC II classification) were recorded. Statistical analyses included the chi-squared test and Fisher's exact test as appropriate. Results. The mean patient age was 75.4 years. Stable plaque phenotypes (Plaque-RADS types 1, 2, and 3a) were overwhelmingly associated with stenosis <70% (90%, 100%, and 85.7% of cases, respectively; P <.001). Patients with ABI >0.3 more frequently harbored lower-risk plaque types (P = .038). Higher anatomical complexity (TASC C/D) was associated with a significantly greater prevalence of high-risk plaque types 3a, 3b, 4a, and 4b (50%, 66.7%, 75%, and 100%, respectively; P=.004–.005). Conclusion. While stenosis severity largely correlates with plaque morphological risk, a subset of patients with non-obstructive lesions harbors high-risk plaque phenotypes that would be missed by hemodynamic criteria alone. Plaque-RADS should be integrated as a complementary stratification tool alongside luminal grading in patients with systemic atherosclerosis.
No takes yet. Share an insight, caveat, or question.
A 2026 study conducted a cross-sectional in chronic limb-threatening ischemia (CLTI) (n=130). Plaque-RADS categories was evaluated on Association of stable plaque phenotypes (Plaque-RADS types 1, 2, and 3a) with stenosis <70% (p=<.001). Stable plaque phenotypes (Plaque-RADS types 1, 2, and 3a) were associated with stenosis <70%.
Synapse has enriched 10 related papers. Consider them for comparative context: